Dendritic cells and the assessment in vitro of skin sensitizing potential

Cutaneous and Ocular Toxicology

Volumn 32, Issue 1, 2013, Pages 54-59

  Kimber, Ian ^a   Dearman, Rebecca J ^a   Basketter, David A ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b DABMEB CONSULTANCY LTD   (United Kingdom)

Author keywords

Dendritic cells; Hazard identification; Langerhans cells; Skin sensitization

Indexed keywords

ALLERGEN; ANTIGEN; CHEMICAL AGENT; LANGERIN;

ADAPTIVE IMMUNITY; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL MIGRATION; CELL VIABILITY; CYTOLOGY; DENDRITIC CELL; EPIDERMIS; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LANGERHANS CELL; LIPOPHILICITY; NONHUMAN; PHENOTYPE; REVIEW; SKIN; SKIN SENSITIZATION; SKIN TOXICITY; T LYMPHOCYTE;

ALLERGENS; ANIMALS; BIOLOGICAL ASSAY; DERMATITIS, ALLERGIC CONTACT; HUMANS; LANGERHANS CELLS; SKIN TESTS;

EID: 84868516182     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2012.692135     Document Type: Review

References (64)

1. Jowsey IR, Basketter DA, Westmoreland C, Kimber I. A future approach to measuring relative skin sensitising potency: A proposal. J Appl Toxicol 2006;26:341-350
2. Basketter DA, Kimber I. Updating the skin sensitization in vitro data assessment paradigm in 2009. J Appl Toxicol 2009;29:545-550
3. Casati S, Aeby P, Basketter DA, Cavani A, Gennari A, Gerberick GF et al.; Report and Recommendations of ECVAM Workshop 51. Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern Lab Anim 2005;33:47-62
4. dos Santos GG, Reinders J, Ouwehand K, Rustemeyer T, Scheper RJ, Gibbs S. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol Appl Pharmacol 2009;236:372-382
5. Kimber I, Cumberbatch M, Betts CJ, Dearman RJ. Dendritic cells and skin sensitisation hazard assessment. Toxicol In Vitro 2004;18:195-202
6. Ryan CA, Hulette BC, Gerberick GF. Approaches for the development of cell-based in vitro methods for contact sensitization. Toxicol In Vitro 2001;15:43-55
7. Vandebriel RJ, van Loveren H. Non-animal sensitization testing: State-of-the-art. Crit Rev Toxicol 2010;40:389-404
8. Kimber I, Basketter DA, Gerberick GF, Ryan CA, Dearman RJ. Chemical allergy: Translating biology into hazard characterization. Toxicol Sci 2011;120 Suppl 1:S238-S268
9. Kaplan DH, Igyártó BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 2012;12:114-124
10. Sasaki Y, Aiba S. Dendritic cells and contact dermatitis. Clin Rev Allergy Immunol 2007;33:27-34
11. Ryan CA, Kimber I, Basketter DA, Pallardy M, Gildea LA, Gerberick GF. Dendritic cells and skin sensitization: Biological roles and uses in hazard identification. Toxicol Appl Pharmacol 2007;221:384-394
12. Toebak MJ, Gibbs S, Bruynzeel DP, Scheper RJ, Rustemeyer T. Dendritic cells: Biology of the skin. Contact Derm 2009;60:2-20
13. Breit R. The Langerhans cell: The master key to contact dermatitis: A hypothesis. Arch Dermatol Res 1982;272:401-405
14. Neves BM, Gonçalo M, Figueiredo A, Duarte CB, Lopes MC, Cruz MT. Signal transduction profile of chemical sensitisers in dendritic cells: An endpoint to be included in a cell-based in vitro alternative approach to hazard identification? Toxicol Appl Pharmacol 2011;250:87-95
15. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992;89:1398-1402
16. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1 β in the initiation of primary immune responses in skin. J Immunol 1993;150:3698-3704
17. Reutter K, Jäger D, Degwert J, Hoppe U. In vitro model for contact sensitization: II. Induction of IL-1β mRNA in human bloodderived dendritic cells by contact sensitizers. Toxicol In Vitro 1997;11:619-626
18. Degwert J, Steckel F, Hoppe U, Kligman LH. In vitro model for contact sensitization: I. Stimulatory capacities of human bloodderived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. Toxicol In Vitro 1997;11:613-618
19. De Smedt AC, Van Den Heuvel RL, Zwi Berneman N, Schoeters GE. Modulation of phenotype, cytokine production and stimulatory function of CD34+-derived DC by NiCl(2) and SDS. Toxicol In Vitro 2001;15:319-325
20. Pichowski JS, Cumberbatch M, Dearman RJ, Basketter DA, Kimber I. Allergen-induced changes in interleukin 1 β (IL-1 β) mRNA expression by human blood-derived dendritic cells: Interindividual differences and relevance for sensitization testing. J Appl Toxicol 2001;21:115-121
21. Gilmour NJ, Basketter DA. Use of dendritic cells for the identification of skin allergens. Int J Cos Sci 2003;6:287-294
22. Reuter H, Spieker J, Gerlach S, Engels U, Pape W, Kolbe L et al. In vitro detection of contact allergens: Development of an optimized protocol using human peripheral blood monocytederived dendritic cells. Toxicol In Vitro 2011;25:315-323
23. Ebner S, Lenz A, Reider D, Fritsch P, Schuler G, Romani N. Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin. Immunobiology 1998;198:568-587
24. Hooyberghs J, Schoeters E, Lambrechts N, Nelissen I, Witters H, Schoeters G et al. A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol Appl Pharmacol 2008;231:103-111
25. Lambrechts N, Nelissen I, Van Tendeloo V, Witters H, Van Den Heuvel R, Hooyberghs J et al. Functionality and specificity of gene markers for skin sensitization in dendritic cells. Toxicol Lett 2011;203:106-110
26. Ashikaga T, Hoya M, Itagaki H, Katsumura Y, Aiba S. Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol In Vitro 2002;16:711-716
27. Ashikaga T, Yoshida Y, Hirota M, Yoneyama K, Itagaki H, Sakaguchi H et al. Development of an in vitro skin sensitization test using human cell lines: The human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol In Vitro 2006;20:767-773
28. Sakaguchi H, Ashikaga T, Miyazawa M, Yoshida Y, Ito Y, Yoneyama K et al. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol In Vitro 2006;20:774-784
29. Sakaguchi H, Ashikaga T, Miyazawa M, Kosaka N, Ito Y, Yoneyama K et al. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test-human cell line activation test (h-CLAT). Cell Biol Toxicol 2009;25:109-126
30. Sakaguchi H, Ryan C, Ovigne JM, Schroeder KR, Ashikaga T. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. Toxicol In Vitro 2010;24:1810-1820
31. Basketter DA, Clewell H, Kimber I, Rossi A, Blaauboer B, Burrier R et al. A roadmap for the development of alternative (nonanimal) methods for systemic toxicity testing - t4 report ALTEX 2012;29:3-91
32. Maxwell G, Aeby P, Ashikaga T, Bessou-Touya S, Diembeck W, Gerberick F et al. Skin sensitisation: The Colipa strategy for developing and evaluating non-animal test methods for risk assessment. ALTEX 2011;28:50-55
33. Goebel C, Aeby P, Ade N, Alépée N, Aptula A, Araki D et al. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: Skin sensitisation. Regul Toxicol Pharmacol 2012;63:40-52
34. Ashikaga T, Sakaguchi H, Sono S, Kosaka N, Ishikawa M, Nukada Y et al. A comparative evaluation of in vitro skin sensitisation tests: The human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern Lab Anim 2010;38:275-284
35. Nukada Y, Ashikaga T, Sakaguchi H, Sono S, Mugita N, Hirota M et al. Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT). Contact Derm 2011;65:343-353
36. United Nations. (2011). Globally Harmonized System of Classification and Labelling of Chemicals (GHS). Part 3: Health Hazards. Available at: http://www.unece.org/fileadmin/DAM/trans/danger/publi/ghs/ghs-rev04/English/ ST-SG-AC10-30-Rev4e.pdf. Accessed on: 23rd March 2012
37. Rambukkana A, Pistoor FH, Bos JD, Kapsenberg ML, Das PK. Effects of contact allergens on human Langerhans cells in skin organ culture: Migration, modulation of cell surface molecules, and early expression of interleukin-1 β protein. Lab Invest 1996;74:422-436
38. Jacobs JJ, Lehé CL, Hasegawa H, Elliott GR, Das PK. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 2006;15:432-440
39. Lehé CL, Jacobs JJ, Hua CM, Courtellemont P, Elliott GR, Das PK. Subtoxic concentrations of allergenic haptens induce LC migration and maturation in a human organotypic skin explant culture model: A novel method for identifying potential contact allergens. Exp Dermatol 2006;15:421-431
40. Watanabe H, Gaide O, Pétrilli V, Martinon F, Contassot E, Roques S et al. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007;127:1956-1963
41. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Dürr C et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med 2008;205:2151-2162
42. Antonopoulos C, Cumberbatch M, Mee JB, Dearman RJ, Wei XQ, Liew FY et al. IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol 2008;83:361-367
43. Weber FC, Esser PR, Müller T, Ganesan J, Pellegatti P, Simon MM et al. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J Exp Med 2010;207:2609-2619
44. Schmidt M, Raghavan B, Müller V, Vogl T, Fejer G, Tchaptchet S et al. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol 2010;11:814-819
45. Martin SF, Esser PR, Weber FC, Jakob T, Freudenberg MA, Schmidt M et al. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 2011;66:1152-1163
46. Kimber I, Cumberbatch M. Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol Appl Pharmacol 1992;117:137-146
47. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CE. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 2000;142:401-412
48. Kimber I, Dearman RJ, Cumberbatch M, Huby RJ. Langerhans cells and chemical allergy. Curr Opin Immunol 1998;10:614-619
49. Griffiths CE, Dearman RJ, Cumberbatch M, Kimber I. Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine 2005;32:67-70
50. Guilliams M, Henri S, Tamoutounour S, Ardouin L, Schwartz-Cornil I, Dalod M et al. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol 2010;40:2089-2094
51. Bennett CL, Noordegraaf M, Martina CA, Clausen BE. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 2007;179:6830-6835
52. Noordegraaf M, Flacher V, Stoitzner P, Clausen BE. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J Invest Dermatol 2010;130:2752-2759
53. Edelson BT, KC W, Juang R, Kohyama M, Benoit LA, Klekotka PA et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells. J Exp Med 2010;207:823-836
54. Igyarto BZ, Kaplan DH. The evolving function of Langerhans cells in adaptive skin immunity. Immunol Cell Biol 2010;88:361-365
55. Kaplan DH. In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol 2010;31:446-451
56. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008;29:497-510
57. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005;23:611-620
58. Bobr A, Olvera-Gomez I, Igyarto BZ, Haley KM, Hogquist KA, Kaplan DH. Acute ablation of Langerhans cells enhances skin immune responses. J Immunol 2010;185:4724-4728
59. Kautz-Neu K, Noordegraaf M, Dinges S, Bennett CL, John D, Clausen BE et al. Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 2011;208:885-891
60. Shklovskaya E, O'Sullivan BJ, Ng LG, Roediger B, Thomas R, Weninger W et al. Langerhans cells are precommitted to immune tolerance induction. Proc Natl Acad Sci USA 2011;108:18049-18054
61. Yoshiki R, Kabashima K, Sugita K, Atarashi K, Shimauchi T, Tokura Y. IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J Invest Dermatol 2009;129:705-713
62. Schwarz A, Noordegraaf M, Maeda A, Torii K, Clausen BE, Schwarz T. Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol 2010;130:1419-1427
63. Cumberbatch M, Clelland K, Dearman RJ, Kimber I. Impact of cutaneous IL-10 on resident epidermal Langerhans' cells and the development of polarized immune responses. J Immunol 2005;175:43-50
64. Watanabe H, Gaide O, Pétrilli V, Martinon F, Contassot E, Roques S et al. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007;127:1956-1963